Tomosynthesis, commonly called 3D mammography, is a breast imaging technique that takes multiple X-ray images from different angles and reconstructs them into thin, one-millimeter slices of breast tissue. It detects about 1 additional cancer per 1,000 screenings compared to standard 2D mammography, while also reducing the number of women called back for unnecessary follow-up imaging by roughly 33%.
How 3D Mammography Works
During a tomosynthesis scan, the X-ray tube moves in an arc above the compressed breast, sweeping anywhere from 15 to 60 degrees depending on the machine. As it moves, it captures multiple low-dose images from slightly different angles. Software then reconstructs these projections into a stack of thin slices, each about one millimeter thick, that a radiologist can scroll through layer by layer.
Think of it like slicing a loaf of bread. A standard 2D mammogram captures the entire breast compressed into a single flat image, so tissues overlap and can hide abnormalities. Tomosynthesis lets the radiologist examine each thin slice individually, separating structures that would otherwise sit on top of one another. This is the core advantage: the ability to see through overlapping tissue rather than looking at everything stacked together.
The machine uses one of two approaches to capture these images. Some systems move continuously while firing X-rays, which is faster but can introduce slight blurring. Others use a “step-and-shoot” method, pausing at each position before taking the image. This produces sharper pictures but takes a bit longer, which increases the chance of motion artifacts if the patient shifts.
What the Screening Experience Feels Like
From a patient’s perspective, tomosynthesis feels very similar to a standard mammogram. Your breast is positioned on the same type of plate and compressed between two surfaces. The main difference is that the scan takes slightly longer because the X-ray arm needs to sweep through its arc, so your breast stays compressed for a few extra seconds.
Research on compression has produced encouraging findings. Studies show that tomosynthesis may be performed with roughly half the compression force used in standard mammography, with no meaningful loss in image quality. In one study, reducing compression force by 45 to 50% significantly lowered perceived pain while the breast thickness changed by less than a millimeter in most views, and tissue coverage stayed the same. That said, current clinical practice still typically uses standard compression levels, so this is an area where the experience could improve over time.
Cancer Detection Rates
A large study published in the Journal of the National Cancer Institute compared outcomes for women aged 40 to 64 screened with either 2D or 3D mammography. Tomosynthesis detected 4.9 cancers per 1,000 screenings, compared to 3.8 per 1,000 with standard mammography. That difference of about 1 additional cancer per 1,000 screens is consistent across multiple studies and may sound small, but across millions of women screened each year, it translates to thousands of cancers caught earlier.
The improvement is most pronounced for invasive cancers, which are the ones that have the potential to spread beyond the breast. Tomosynthesis does come with slightly higher biopsy rates (19.6 per 1,000 screens versus 15.2), meaning more women undergo biopsies that turn out to be benign. This is a tradeoff: more cancers found, but also more false alarms that lead to biopsies.
Why It Matters for Dense Breasts
Dense breast tissue is made up of more glandular and connective tissue relative to fatty tissue. On a standard mammogram, both dense tissue and tumors appear white, which means cancers can hide in plain sight. Up to 27% of breast cancers are missed in dense breasts using conventional 2D imaging.
Tomosynthesis directly addresses this problem. By separating tissue into individual slices, it eliminates the overlapping layers that mask tumors in dense breasts. It also helps radiologists distinguish between real abnormalities and areas where normal tissue simply overlaps in a way that mimics a suspicious finding. This is particularly valuable for identifying architectural distortions, subtle changes in the tissue pattern that can signal cancer but are easily confused with overlapping dense tissue on a flat image.
Roughly half of women in their 40s and a significant portion of older women have dense breast tissue, so this isn’t a niche benefit. The USPSTF currently considers both digital mammography and tomosynthesis effective screening methods but has not yet made a separate recommendation specifically for women with dense breasts regarding supplemental screening with ultrasound or MRI.
Fewer Callbacks and False Positives
One of the most practical benefits of tomosynthesis is the reduction in recall rates. Being called back after a mammogram for additional imaging is stressful, and it happens frequently with 2D screening, particularly during a woman’s first (baseline) mammogram. In one prospective trial, the recall rate for women without cancer dropped from 38.4% with 2D mammography alone to 25.5% when tomosynthesis was added. That is a 33% reduction.
Modeling data from the USPSTF estimated that screening women aged 40 to 74 with tomosynthesis instead of digital mammography would result in 167 fewer false-positive results per 1,000 women screened. Fewer false positives mean fewer unnecessary biopsies, less anxiety, and lower overall costs.
Radiation Dose
Tomosynthesis does involve somewhat more radiation than a single 2D mammogram. For a breast of average thickness (about 6 centimeters), a 3D scan delivers roughly 4 to 6 milligray per breast, compared to a range that starts lower for 2D imaging. Many facilities use a “combo mode” that acquires both a 2D and 3D image during the same visit, which gives radiologists both views to compare but does increase the total dose.
To reduce this, newer systems generate a “synthetic” 2D image from the 3D data rather than taking a separate 2D exposure. This brings the total radiation closer to what you would receive from a standard mammogram alone. The doses involved remain well within safety limits established for breast cancer screening.
Where Tomosynthesis Falls Short
Tomosynthesis is not equally better at finding every type of breast abnormality. Its most notable limitation involves calcifications, tiny calcium deposits that can be an early sign of certain breast cancers. Because the 3D images have slightly lower spatial resolution than standard mammograms (due to tube motion and larger pixel sizes), some calcifications appear less sharp or less suspicious, and a few may not be visible at all.
In one study of 99 cases with malignant calcifications, tomosynthesis alone detected 80% compared to 90% with standard mammography. Another study with 41 malignant calcification cases found 91% sensitivity for tomosynthesis versus 100% for 2D. These gaps are why many facilities continue to use both modalities together rather than relying on tomosynthesis alone, and why standard stereotactic biopsy techniques are still needed when calcifications are too fine for the 3D system to target accurately.
There is also the question of “tomo-only” lesions, abnormalities visible on tomosynthesis that cannot be seen on any conventional imaging, even in hindsight. Managing these findings requires tomosynthesis-guided biopsy, which is accurate but not yet universally available at every imaging center.
Screening vs. Diagnostic Use
Tomosynthesis serves two distinct roles. As a screening tool, it is used in routine breast cancer checks for women with no symptoms, where its main advantages are higher cancer detection and fewer false alarms. As a diagnostic tool, it helps evaluate a specific area of concern, such as a lump felt during a clinical exam or an ambiguous finding on a previous mammogram.
In diagnostic settings, the ability to scroll through tissue slices is especially useful for characterizing lesions in dense breasts and for determining whether an apparent abnormality is a real mass or just overlapping tissue. This can spare patients from additional imaging visits or unnecessary biopsies. The USPSTF recognizes tomosynthesis as an effective screening modality alongside standard digital mammography, and most insurance plans in the United States now cover it for routine screening.